Crowdonomics
WatchlistPortfolio
All companies

BioLIfe Sciences Inc

Operating

Biotech · Henderson, NV

Estimated pre-money ⓘ
$15.7M
As of May 2022 · from Reg A Offering (2022) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$0
Across 1 round since 2022
Latest share price
$0.275
Reg A Offering (2022) offering price

Financials

FY2021 · from SEC filings · hover any figure for its source
$0
−$783K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
Income statement
Revenue
$0
Cost of goods sold
-$782,825
Net income
-$782,825
Balance sheet
Cash
$265,623
Accounts receivable
$340,238
Total assets
$1,610,441
Long-term debt
$310,945
Total liabilities
$1,237,864
Other
Headcount
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$15.7M
est. pre-money
Reg A+ · Equity · May 2022

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Mar 30, 2023
ClassOutstandingVotes / shareShare of totalLast price
Common771,831,732—100.0%—

Shares outstanding over timein today's share terms

772M386M0
May 2022Feb 2023
Common

Principal holders% as the filing states it, Mar 30, 2023

  • Nika Jasic1,000,000 Common Shares10.0%of company

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · May 2022Closed
Raised $0 / $20MEst. pre-money $15.7M

Team

3 people
Justin De Four
Chairman and CEO & Director
Nika Jaksic
Chief Operating Officer
Brian Morales
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

SEC filings

View all 18 filings on EDGAR
  • Form 253G1Apr 6, 20230001477932-23-002282
    EDGAR
  • Form QUALIFApr 5, 20239999999994-23-000148
    EDGAR
  • Form 1-A POSMar 30, 20230001477932-23-001897
    EDGAR
  • Form 253G2Feb 22, 20230001477932-23-001204
    EDGAR
  • Form 253G1Feb 21, 20230001477932-23-001172
    EDGAR
  • Form 1-A POSFeb 17, 20230001477932-23-001113
    EDGAR
  • Form QUALIFFeb 17, 20239999999994-23-000070
    EDGAR
  • Form 1-A POSFeb 9, 20230001477932-23-000846
    EDGAR
Source: SEC EDGARCIK 0001929281FLShare price $0.275Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.